Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (4467)	6/12/1998 1:10:00 AM
From: Steve Fancy	Read Replies (2) \| Respond to of 6136

Richard, Thanks for the feedback. After reading the press release a couple of times, I really warmed up to the idea. My confidence in Agouron's future is building. This seems like it may be a slick strategic move. Regarding the information due to be released at the Aids conference...do the non-insider chemists and scientists of the world have any upfront means of obtaining results of these studies through scientific journals etc, or would we expect this to be completely fresh news. Assuming the latter, sounds like the news has the potential to start moving AGPH out of the trading range its been stuck in for so long. Thanks again, sf